Authors

• Author: Claas Junghans/Adam Levy/Rolf Sander/Tobias Boeckh/Jan Dirk Heerma/Christoph Regierer
• Pages: 15-15

XV

Authors

Claas Junghans studied chemistry, molecular biology and intellectual property law

in Berlin and has held senior management positions in several biotechnology

companies.

Adam Levy has a Natural Sciences degree from Cambridge University and an

MBA from INSEAD, Paris, and has held senior management and board positions

in several start-up biotechnology companies.

Rolf Sander studied chemistry and physics, and practices intellectual property law

as an in-house counsel for Siemens AG, and as German and European patent

attorney at Stapel Rechtsanwlte, Berlin.

Tobias Boeckh studied chemistry and biochemistry in Berlin and practices patent

law, trademark and design protection as a partner at Hertin, a law firm based in

Berlin.

Jan Dirk Heerma is a partner in the Berlin office of the pan-european law firm

SJ Berwin. He is head of SJ Berwin’s Technology Group in Germany and specia-

lises on licensing and R&D agreements and the IP-aspects of corporate transac-

tions.

Christoph Regierer is a tax-lawyer and chartered auditor and practices corporate

and tax law as a senior partner of Rver & Partner in Berlin. He is chairman of

the European Fiscal and Tax Groupof Moores Rowland International.